Influenza Vaccination

In light of sparse data regarding vaccine prevention of influenza in children aged 6 to 35 months, researchers recently assessed the safety and efficacy of the inactivated quadrivalent influenza vaccine vs...

The US Food and Drug Administration advisory committee has released its recommendations regarding the components of the 2018-2019 influenza vaccine.

Researchers recently evaluated the effects of influenza vaccination on postoperative pneumonia and in-hospital mortality risks among geriatric patients who underwent major surgery.

Older adults have an increased risk of influenza. In a recent study, researchers evaluated the relationship between antibody-dependent cellular cytotoxicity and vaccine responsiveness in this patient...

This program was first introduced during the 2013-2014 influenza season. In a recent study, researchers evaluated its impact on the burden of influenza among healthy school-age children being cared for in a...

The influenza vaccine may provide a “back-boost” to antibodies against previously encountered strains of influenza. In a recent study, researchers evaluated the effects of the updated 2015-2016 inactivated...

The ACAAI and AAAAI task force recently released new practice parameters for administering the influenza vaccine to patients with egg allergies.

Infants younger than 6 months have an increased risk for severe influenza-related complications. In a recent study, researchers explored whether receiving a prenatal or postpartum influenza vaccination...

In a recent study, researchers evaluated the effectiveness of the influenza vaccine over the course of 4 influenza seasons through 2014.

The CDC recommended against using the live attenuated influenza vaccine (LAIV) during the 2016-2017 influenza season. However, the perceived effectiveness and ease of administration of LAIV play an...